Progress of Gastric Cancer Surgery in the era of Precision Medicine

Wang, Yumin; Zhang, Luyuan; Yang, Yi; Lu, Shan; Chen, Hao

doi:10.7150/ijbs.56735



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2021; 17(4):1041-1049. doi:10.7150/ijbs.56735 This issue Cite

Review

Progress of Gastric Cancer Surgery in the era of Precision Medicine

Yumin Wang^1,2#, Luyuan Zhang^3#, Yi Yang⁴, Shan Lu⁵, Hao Chen^1✉

1. Department of General Surgery, The First Affiliated Hospital of USTC; Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
2. Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
3. Department of Neurosurgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
4. Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
5. Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
#These authors contributed equally to this work.

Citation:

Wang Y, Zhang L, Yang Y, Lu S, Chen H. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci 2021; 17(4):1041-1049. doi:10.7150/ijbs.56735. https://www.ijbs.com/v17p1041.htm

Other styles

Abstract

With the development of genomics, the update of modern imaging technology and the advent of artificial intelligence and big data, the surgical treatment of gastric cancer has gradually stepped into precision medicine. Precision surgery treatment of gastric cancer is based on accurate molecular typing and staging using modern molecular diagnostic technology and imaging, and the formulation of precise and individualized surgical treatment plans, with the concept of minimally invasive and accelerated rehabilitation surgery running through it. For intermediate-stage gastric cancer, we have adopted a comprehensive treatment approach including traditional radiotherapy and chemotherapy, targeted therapy and immunotherapy. Utilize artificial intelligence and big data technology to improve the standardization and interconnectivity of specialty data and realize the transformation of evidence-based medicine. Promoting the standardization, standardization and individualization of gastric cancer surgical treatment, providing patients with precise diagnosis and treatment, and further improving patients' prognosis are the opportunities and challenges in the development of gastric cancer surgery.

Keywords: gastric cancer, surgery, precision medicine, chemotherapy, immunotherapy

Citation styles

APA

Wang, Y., Zhang, L., Yang, Y., Lu, S., Chen, H. (2021). Progress of Gastric Cancer Surgery in the era of Precision Medicine. International Journal of Biological Sciences, 17(4), 1041-1049. https://doi.org/10.7150/ijbs.56735.

ACS

Wang, Y.; Zhang, L.; Yang, Y.; Lu, S.; Chen, H. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int. J. Biol. Sci. 2021, 17 (4), 1041-1049. DOI: 10.7150/ijbs.56735.

NLM

CSE

Wang Y, Zhang L, Yang Y, Lu S, Chen H. 2021. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci. 17(4):1041-1049.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.